Minerva

Potassium intake and cardiovascular outcomes and other stories . . .

BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2294 (Published 28 April 2016) Cite this as: BMJ 2016;353:i2294

Dengue: the billion dollar question

The global cost of dengue is $3.7-19.7bn, concludes a study on its economic burden across 141 countries and territories (Lancet Infect Dis doi:10.1016/S1473-3099(16)00146-8). The study was funded by Sanofi Pasteur, which has marketed the first dengue vaccine, Dengvaxia. It is currently available in the Philippines at about £270 a course. Given that half the world’s population is at risk, mostly in low-to-middle income countries, there seems to be a mismatch.

Palliative gap for Parkinson’s

Parkinson’s disease can shorten life, have a high symptom burden, and require structured support, but patients seldom receive palliative care. A qualitative study (Neurol Clin Pract doi:10.1212/CPJ.0000000000000233) shows that most patients are highly receptive to palliative care to help them cope with psychosocial problems, adjustment to illness, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe